摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2S,5R)-5-(2,6-二氨基嘌呤-9-基)-2,5-二氢呋喃-2-基]甲醇 | 109881-25-6

中文名称
[(2S,5R)-5-(2,6-二氨基嘌呤-9-基)-2,5-二氢呋喃-2-基]甲醇
中文别名
——
英文名称
2,6-diamino-9-(2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)purine
英文别名
[(2S,5R)-5-(2,6-diaminopurin-9-yl)-2,5-dihydrofuran-2-yl]methanol
[(2S,5R)-5-(2,6-二氨基嘌呤-9-基)-2,5-二氢呋喃-2-基]甲醇化学式
CAS
109881-25-6
化学式
C10H12N6O2
mdl
——
分子量
248.244
InChiKey
QVRGWJZTKCMSIW-NTSWFWBYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    125
  • 氢给体数:
    3
  • 氢受体数:
    7

安全信息

  • 海关编码:
    2934999090

SDS

SDS:51492e32267d3407189ed80e1f0f87ad
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of sugar-modified 2,6-diaminopurine and guanine nucleosides from guanosine via transformations of 2-aminoadenosine and enzymatic deamination with adenosine deaminase
    作者:Morris J. Robins、Ruiming Zou、Fritz Hansske、Stanislaw F. Wnuk
    DOI:10.1139/v97-092
    日期:1997.6.1
    of 2,6-diaminopurine riboside (2-aminoadenosine) with α-acetoxyisobutyryl bromide in acetonitrile gave mixtures of the trans 2′,3′-bromohydrin acetates 2. Treatment of 2 with zinc–copper couple effected reductive elimination, and deprotection gave 2,6-diamino-9-(2,3-dideoxy-β-D-erythro-pent-2-enofuranosyl)purine (3a). Treatment of 2 with Dowex 1 × 2 (OH−) resin in methanol gave the 2′,3′-anhydro derivative
    在乙腈中用 α-乙酰氧基异丁酰溴处理 2,6-二氨基嘌呤核苷(2-氨基腺苷)得到反式 2',3'-溴醇乙酸酯的混合物 2。用锌-铜对处理 2 实现还原消除,脱保护得到2,6-diamino-9-(2,3-dideoxy-β-D-erythro-pent-2-enofuranosyl)purine (3a)。在甲醇中用 Dowex 1 × 2 (OH-) 树脂处理 2 得到 2',3'-脱水衍生物 4。甲硅烷基自由基介导的 2 氢解和脱保护得到 2'-脱氧 6a 和 3'-脱氧 7a 核苷. 用三氟甲磺酰氯 - 4-(二甲氨基)吡啶处理 3',5'-O-(四异丙基二硅氧烷基)衍生物 (5a) 得到 2'-三氟甲磺酸酯 5c。用叠氮化锂-二甲基甲酰胺置换并脱保护得到阿拉伯 2'-叠氮衍生物 8a,将其还原为 2,6-diamino-9-(2-amino-2-deoxy-β-D-arabinofuranosyl)purine
  • Nucleic Acid-Related Compounds. 88. Efficient Conversions of Ribonucleosides into Their 2',3'-Anhydro, 2'(and 3')-Deoxy, 2',3'-Didehydro-2',3'-dideoxy, and 2',3'-Dideoxynucleoside Analogs
    作者:Morris J. Robins、John S. Wilson、Danuta Madej、Nicholas H. Low、Fritz Hansske、Stanislaw F. Wnuk
    DOI:10.1021/jo00129a034
    日期:1995.12
    Treatment of purine, pyrimidine, and modified purine (antibiotic) ribonucleosides with 2-acetoxy-2-methylpropanoyl (alpha-acetoxyisobutyryl) bromide in acetonitrile gave mixtures of 2',3'-bromohydrin acetates with different O5' substituents. Significant amounts of 5'-unprotected (hydroxyl) bromo acetates were obtained in some cases, and formation of 2',3'-O-isopropylidene derivatives as minor byproducts was detected for the first time. Acid-catalyzed nucleophilic displacement of chloride by bromide occurred with 2-amino-6-chloropurine riboside, but no substitution of fluoride by bromide was detected with 6-amino-2-fluoropurine riboside. Treatment of the trans bromo acetate mixtures obtained from purine-type nucleosides with Dowex 1 x 2 (OH-) in methanol gave the 2',3'-anhydro (ribo epoxide) compounds. Radical-mediated hydrogenolytic debromination and deprotection gave 2'- and 3'-deoxynucleosides. Treatment of the bromo acetate mixtures with zinc-copper couple or acetic acid-activated zinc effected reductive elimination, and deprotection gave 2',3'-didehydro-2',3'-dideoxy compounds which were hydrogenated to give 2',3'-dideoxynucleosides. A number of these analogues have potent inhibitory activity against AIDS and hepatitis B viruses. New C-13 NMR data for several types of unsaturated-sugar nucleosides are tabulated. These procedures are directly applicable for the preparation of L-didehydro-dideoxy and L-dideoxy nucleoside analogues.
  • Robins, Morris J.; Wilson, John S.; Madej, Danuta, Journal of Heterocyclic Chemistry, 2001, vol. 38, # 6, p. 1297 - 1306
    作者:Robins, Morris J.、Wilson, John S.、Madej, Danuta、Tyrrell, D. Lorne J.、Gati, Wendy P.、Lindmark、Wnuk, Stanislaw F.
    DOI:——
    日期:——
查看更多